Display options
Cite
Konstantinidou SK, Argyrakopoulou G, Tentolouris N, et al. Interplay between baroreflex sensitivity, obesity and related cardiometabolic risk factors (Review). Exp Ther Med. 2021;23(1):67doi: 10.3892/etm.2021.10990.
Konstantinidou, S. K., Argyrakopoulou, G., Tentolouris, N., Karalis, V., & Kokkinos, A. (2022). Interplay between baroreflex sensitivity, obesity and related cardiometabolic risk factors (Review). Experimental and therapeutic medicine, 23(1), 67. https://doi.org/10.3892/etm.2021.10990
Konstantinidou, Sofia K, et al. "Interplay between baroreflex sensitivity, obesity and related cardiometabolic risk factors (Review)." Experimental and therapeutic medicine vol. 23,1 (2022): 67. doi: https://doi.org/10.3892/etm.2021.10990
Konstantinidou SK, Argyrakopoulou G, Tentolouris N, Karalis V, Kokkinos A. Interplay between baroreflex sensitivity, obesity and related cardiometabolic risk factors (Review). Exp Ther Med. 2022 Jan;23(1):67. doi: 10.3892/etm.2021.10990. Epub 2021 Nov 23. PMID: 34934438; PMCID: PMC8649854.
Copy Download .nbib Format: NLM
Share it on

Exp Ther Med. 2022 Jan;23(1):67. doi: 10.3892/etm.2021.10990. Epub 2021 Nov 23.

Interplay between baroreflex sensitivity, obesity and related cardiometabolic risk factors (Review).

Experimental and therapeutic medicine

Sofia K Konstantinidou, Georgia Argyrakopoulou, Nicholas Tentolouris, Vangelis Karalis, Alexander Kokkinos

Affiliations

  1. First Department of Propaedeutic Internal Medicine, School of Medicine, National and Kapodistrian University of Athens, Laiko General Hospital, 11527 Athens, Greece.
  2. Diabetes and Obesity Unit, Athens Medical Center, 15125 Athens, Greece.
  3. Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, 15784 Athens, Greece.

PMID: 34934438 PMCID: PMC8649854 DOI: 10.3892/etm.2021.10990

Abstract

The baroreflex represents a rapid negative feedback system implicated in blood pressure regulation, which aims to prevent blood pressure variations by regulating peripheral vascular tone and cardiac output. The aim of the present review was to highlight the association between baroreflex sensitivity (BRS) and obesity, including factors associated with obesity, such as metabolic syndrome, hypertension, cardiovascular disease and diabetes. For the present review, a literature search was conducted using the PubMed database until August 21, 2021. The searched terms included 'baroreflex', and other terms such as 'sensitivity', 'obesity', 'metabolic syndrome', 'hypertension', 'diabetes', 'gender', 'aging', 'children', 'adolescents', 'physical activity', 'bariatric surgery', 'autonomous nervous system' and 'cardiometabolic risk factors'. Obesity and its related metabolic disorders can influence baroreflex functionality and decrease BRS, mostly by potentiating sympathetic nervous system activity. Obesity induces inflammation, which can increase sympathetic system activity and lead to a higher incidence of cardiovascular events. Obesity also represents an important risk factor for hypertension through numerous mechanisms; in this setting, dysfunctional baroreceptors are not able to protect against constantly elevated blood pressure. Furthermore, diabetes mellitus and oxidative stress result in deterioration of BRS, whereas aging is also generally related to reduced cardiovagal BRS. Differences in BRS have also been observed between men and women, and overall cardiovagal BRS in healthy women is less intense compared with that in men. BRS appears lower in children with obesity compared with that in children of a healthy weight. Notably, physical exercise can increase BRS in both hypertensive and normotensive subjects, and BRS can also be significantly improved following bariatric surgery and weight loss. In conclusion, obesity and its related metabolic disorders may influence baroreflex functionality and decrease BRS, and baroreceptors cannot protect against the constantly elevated blood pressure in obesity. However, following bariatric surgery and weight loss, BRS can be significantly improved. The present review summarizes the role of obesity and related metabolic risk factors in BRS, providing details on possible mechanisms and shedding light on their interplay leading to autonomic neuropathy.

Copyright: © Konstantinidou et al.

Keywords: BRS; autonomic disorders; blood pressure regulation; metabolic syndrome; obesity

Conflict of interest statement

The authors declare that they have no competing interests.

References

  1. Clin Dermatol. 2018 Jan - Feb;36(1):14-20 - PubMed
  2. World J Diabetes. 2018 Jan 15;9(1):1-24 - PubMed
  3. Circulation. 2007 Jan 23;115(3):387-97 - PubMed
  4. Circulation. 2018 Mar 13;137(11):1132-1142 - PubMed
  5. Front Physiol. 2021 Jan 20;11:613311 - PubMed
  6. J Diabetes Complications. 2019 Apr;33(4):278-288 - PubMed
  7. Nutrients. 2019 Jul 21;11(7): - PubMed
  8. Medicine (Baltimore). 2016 Jan;95(2):e2472 - PubMed
  9. Obes Res Clin Pract. 2020 Mar - Apr;14(2):158-163 - PubMed
  10. J Am Coll Cardiol. 2000 Jan;35(1):194-200 - PubMed
  11. Hypertension. 2005 Aug;46(2):321-5 - PubMed
  12. J Hum Hypertens. 2016 Sep;30(9):513-20 - PubMed
  13. Circulation. 1992 Feb;85(2):497-503 - PubMed
  14. Physiol Res. 2010;59(4):517-528 - PubMed
  15. Acta Physiol (Oxf). 2017 Dec;221(4):250-265 - PubMed
  16. Am J Physiol Heart Circ Physiol. 2019 Jun 1;316(6):H1458-H1467 - PubMed
  17. Curr Hypertens Rep. 2020 Jul 15;22(8):55 - PubMed
  18. Am J Physiol Heart Circ Physiol. 2013 Oct 1;305(7):H1080-8 - PubMed
  19. J Physiol Sci. 2019 Nov;69(6):851-859 - PubMed
  20. CNS Neurosci Ther. 2018 Sep;24(9):828-836 - PubMed
  21. PLoS One. 2016 Dec 9;11(12):e0167525 - PubMed
  22. Int J Obes (Lond). 2020 Aug;44(8):1793-1799 - PubMed
  23. Int J Mol Sci. 2021 May 14;22(10): - PubMed
  24. J Physiol. 2020 Jul;598(14):2977-2993 - PubMed
  25. Annu Rev Physiol. 2008;70:537-56 - PubMed
  26. Diabetes. 2020 May;69(5):1011-1019 - PubMed
  27. Obes Surg. 2021 Nov;31(11):4970-4984 - PubMed
  28. Circ J. 2011;75(6):1418-23 - PubMed
  29. Hypertens Res. 2016 Jul;39(7):501-5 - PubMed
  30. N Engl J Med. 2017 Feb 16;376(7):641-651 - PubMed
  31. Front Physiol. 2019 Jul 16;10:845 - PubMed
  32. Circulation. 2009 Oct 20;120(16):1640-5 - PubMed
  33. J Card Fail. 2014 Jan;20(1):53-9 - PubMed
  34. J Hypertens. 2002 May;20(5):927-33 - PubMed
  35. Front Physiol. 2018 Dec 20;9:1829 - PubMed
  36. Front Physiol. 2017 Apr 06;8:203 - PubMed
  37. Am J Physiol Regul Integr Comp Physiol. 2017 Dec 1;313(6):R654-R659 - PubMed
  38. Am J Hypertens. 2021 Dec 1;34(12):1276-1283 - PubMed
  39. Expert Rev Cardiovasc Ther. 2014 Aug;12(8):955-62 - PubMed
  40. Prog Cardiovasc Dis. 2020 Jan - Feb;63(1):4-9 - PubMed
  41. Physiol Rep. 2014 Sep 04;2(9): - PubMed
  42. J Hypertens. 2020 Apr;38(4):565-572 - PubMed
  43. Acta Physiol (Oxf). 2014 Jun;211(2):297-313 - PubMed
  44. Auton Neurosci. 2015 Jan;187:18-26 - PubMed
  45. Am J Physiol Regul Integr Comp Physiol. 2016 Dec 1;311(6):R1271-R1275 - PubMed
  46. Prog Cardiovasc Dis. 2018 Jul - Aug;61(2):157-167 - PubMed
  47. Exerc Sport Sci Rev. 2019 Jul;47(3):129-141 - PubMed
  48. Med Biol Eng Comput. 2011 Mar;49(3):279-88 - PubMed
  49. Peptides. 2013 Jun;44:1-7 - PubMed
  50. J Hypertens. 2005 Nov;23(11):2019-26 - PubMed
  51. Int Heart J. 2019 Mar 20;60(2):241-246 - PubMed
  52. Adv Exp Med Biol. 2017;960:1-17 - PubMed
  53. Herz. 2015 Apr;40 Suppl 2:190-6 - PubMed
  54. High Blood Press Cardiovasc Prev. 2016 Sep;23(3):175-9 - PubMed
  55. Braz J Med Biol Res. 2000 Jan;33(1):51-4 - PubMed
  56. Circ J. 2010 Jul;74(7):1379-83 - PubMed
  57. Hypertension. 2020 Aug;76(2):300-311 - PubMed
  58. J Hum Kinet. 2012 Mar;31:97-104 - PubMed
  59. J Diabetes Res. 2015;2015:341583 - PubMed
  60. J Hypertens. 2003 Jun;21(6):1011-53 - PubMed
  61. Physiol Meas. 2015 Apr;36(4):741-53 - PubMed
  62. J Physiol. 2011 Apr 1;589(Pt 7):1643-62 - PubMed
  63. Int J Mol Sci. 2019 Feb 02;20(3): - PubMed
  64. Acta Physiol Hung. 2011 Mar;98(1):71-84 - PubMed
  65. Metabolism. 2015 Dec;64(12):1704-14 - PubMed
  66. Curr Diabetes Rev. 2006 Aug;2(3):329-38 - PubMed
  67. Am J Hypertens. 2010 Jun;23(6):655-9 - PubMed
  68. Can J Physiol Pharmacol. 2009 Jul;87(7):565-71 - PubMed
  69. Klin Padiatr. 2006 Jul-Aug;218(4):237-42 - PubMed
  70. J Appl Physiol (1985). 2018 Apr 1;124(4):960-969 - PubMed
  71. J Card Fail. 2011 Jun;17(6):519-25 - PubMed
  72. J Vasc Surg. 2006 Sep;44(3):472-9 - PubMed
  73. Am J Physiol. 1996 Sep;271(3 Pt 2):H1139-44 - PubMed
  74. Physiol Res. 2016 Dec 13;65(6):879-889 - PubMed
  75. Metabolism. 2018 Jul;84:67-75 - PubMed
  76. Am J Cardiol. 2013 Dec 1;112(11):1757-62 - PubMed
  77. Sleep Breath. 2019 Mar;23(1):143-151 - PubMed
  78. Adv Physiol Educ. 2017 Dec 1;41(4):578-593 - PubMed
  79. Diabetologia. 2005 Jul;48(7):1359-65 - PubMed
  80. Obesity (Silver Spring). 2013 Jun;21(6):1111-8 - PubMed
  81. Metabolism. 2007 Jul;56(7):919-24 - PubMed
  82. J Clin Invest. 2017 Jan 3;127(1):24-32 - PubMed
  83. Diabetes Care. 2001 Oct;24(10):1793-8 - PubMed
  84. Neuromolecular Med. 2008;10(3):169-78 - PubMed
  85. J Clin Oncol. 2018 Mar 20;36(9):875-883 - PubMed
  86. Clin Physiol Funct Imaging. 2012 Jul;32(4):305-9 - PubMed
  87. Hypertension. 2014 Aug;64(2):431-7 - PubMed
  88. Obes Surg. 2013 Jan;23(1):31-8 - PubMed
  89. Obes Surg. 2013 Nov;23(11):1835-41 - PubMed
  90. Neth Heart J. 2013 Feb;21(2):58-60 - PubMed
  91. J Hypertens. 2006 Feb;24(2):361-70 - PubMed
  92. Cardiol J. 2013;20(5):453-63 - PubMed
  93. Front Physiol. 2017 Sep 14;8:665 - PubMed
  94. J Sports Med Phys Fitness. 2019 Jun;59(6):1036-1044 - PubMed
  95. Clin Auton Res. 2017 Feb;27(1):17-23 - PubMed
  96. Am J Physiol Regul Integr Comp Physiol. 2007 Jul;293(1):R3-R12 - PubMed
  97. Hypertens Res. 2018 Aug;41(8):547-552 - PubMed
  98. Hypertens Res. 2016 Nov;39(11):769-776 - PubMed
  99. J Clin Invest. 2011 Jun;121(6):2111-7 - PubMed
  100. Int J Occup Med Environ Health. 2020 Oct 20;33(6):819-828 - PubMed
  101. Cardiol Rev. 2011 Jan-Feb;19(1):1-4 - PubMed

Publication Types